Related Experiment Video
Updated: Aug 3, 2026

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
ST789: a new synthetic immunomodulator
1Cattedra Malattie Infettive, Dipartimento di Medicina Sperimentale, L'Aquila, Italy.
Abstract:
ST 789 is a synthetic compound which belongs to a new family of hypoxanthine derivatives exhibiting an aminoacidic function at the N-9 position of the purine ring. Available literature indicates that hypoxanthine derivatives exhibit well established immunomodulant properties. Furthermore, the addition of arginine to these molecules proved able to strongly enhance their immunomodulant activity. We review here the immunomodulant properties of both arginine and arginine-containing compounds, and mostly of ST 789.
Related Concept Videos
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Tumor Immunotherapy
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drug Products: Biologics, Biosimilars and Interchangeables

